TreasureGoddess
Member
occupyjapan, WOW AND YAY AND WOOHOO! Glad you got the meds so quick and super glad you're already feeling benefits.
Kenna2, I’m not sure how severe your liver/lung involvement is and don’t mean to question your doctor’s decision; but I did want to make you aware of recommendations for those with hepatic impairment:Just wanted to give everyone a heads up. I went to my CF clinic today and asked about getting a prescription for Orkambi and my doctor, told me that because I have liver disease (brought on by CF) this isn't a med he would recommend for me at the moment due to the risk of more damage Orkambi has been shown to cause. He said most doctors he's talked to are very hesitant to prescribe this med until they can see what it actually does to patients.
2005CFmom,
From my understanding, as long as Orkambi and Kalydeco are prescribed on label, co-pay assistance should be available.
For those of us fortunate to be getting it off label, the co-payments however can be considerable. If it were not for dramatic results the drug is providing, some of us would not have been so willing to absorb the high monthly cost, (5% in my case).
Also, like you, I don't understand why any doctor is reluctant to prescribe Orkambi or Kalydeco, on or off label. Compared to other drugs we're taking, the side effects of these new drugs are not as prevalent or severe. Their positive results can be astounding, enabling many patients to eliminate, or at least reduce, the need for other more dangerous drugs.
Why not at least try to see what Orikambi or Kalydeco can do. From what I've been reading, patients are seeing results in a matter of days. If the drug is not helping, stop it.
I'm seeing more and more how all CF centers are surely not equal. Some are proactive, trying to get their patients drugs off label and via Expanded Access programs, if they think it would help. Fortunately, the three adult CF centers I've had experiences with in the New York area have been proactive. I know this can mean additional paper work on their part both in setting up programs with drug manufactures and in "persuading" insurance providers to cover the drugs. However, it's horrible to think that some CF centers might be too lazy, or uninformed, to provide their patients with the best care that is available.
Good luck in getting a positive response to both co-payment assistance to Orikambi!
2005CFmom,
From my understanding, as long as Orkambi and Kalydeco are prescribed on label, co-pay assistance should be...
...Good luck in getting a positive response to both co-payment assistance to Orikambi!
Stephen,
Could Orkambi be prescribed off label for someone under the approved age? My son is 4 with double Delta and has learned to swallow pills already. We are very anxious for this new treatment to be available to him.
Just wanted to add to Stephen's thoughts on this as our son is 6 and like you we're very anxious. Drugs can be scripted off-label for age or "use" (i.e., mutation). In fact many of the CF drugs are off-label for age (i.e. Pulmozyme) because they can't get studies on lung function for young age and/or can't get study participants (our doctor explained this to use in scripting stuff the first time). With the Vertex drugs, though, they are so new the doctors might not be comfortable doing off label with age when it is a big disparity especially given the issues that have come up re cataracts for young ones. I had originally intended to request off label for our son as soon as approved but because they don't know the dosing for that age (that's what the study for the younger group is), and because of the newness, we are waiting for the study results. They are testing 6-11 now and that will be done in October. Not sure if results will be announced then but definitely early next year. Vertex is also starting a 2-5 study soon.
So you could try to get in the 2-5 study or once approved for 6-11, then I think the doctor would be open to scripting off-label (especially if your little one is 5 and/or close to 5 and especially if close to the weight in the 6-11 study--I just pulled and the study weight says: "Subjects who weigh > 15 kg without shoes at Screening Visit"
https://clinicaltrials.gov/ct2/show/NCT01897233?term=vx809&rank=5
With Kalydeco I know doctors were scripting for those under 6 when it was approved for 6-11. But there would be no co-pay assistance from Vertex so it would depend if you have insurance that covers (i.e. do you have a $60 mail order copay or a 20% copay which could be $$$$$).
Yippe, thanks for sharing..personally I'd l Be any and all little tidbits of any changes you notice once started!